The development and verification of clinical medication pathway for tic disorder in west China
This study actively explored clinical medication pathways for children with TD in China and provided a standardized and highly operable medication pathway for reference in clinical practice. This pathway is expected to be widely used in treatment for children with TD. We suggest that further research should update and improve the clinical medication pathway using the latest evidence.
Authors
- Dan Li (ORCID: https://orcid.org/0000-0002-8841-8991)
- Zhang Jian-hua (ORCID: https://orcid.org/0000-0002-5892-5757)
- Chunsong Yang (ORCID: https://orcid.org/0000-0001-7496-6076)
Institutions
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-06
- DOI
- https://doi.org/10.3389/fphar.2025.1682518
- Primary Topic
- Obsessive-Compulsive Spectrum Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Sichuan Province
- Health and Family Planning Commission of Sichuan Province